Медицина антистарения в офтальмологии: современные представления о профилактике и лечении возрастно-зависимой дегенерации макулы

А. Т. Быков, А. В. Тихонов, Т. Н. Маляренко Кубанский государственный медицинский институт, Ростовская глазная клиника ИнтерЮна

2015 №4 | Лекции

Аннотация

Список литературы

Скачать полнотекстовую статью

Возрастная макулодегенерация (ВМД) – ведущая причина слепоты у пожилых и старых людей в индустриальных странах Европы, в США, Канаде, Японии и Австралии.

Ключевые слова:

возрастно-зависимая дегенерация макулы, факторы риска, лечение, профилактика

Anti-aging medicine in ophthalmology: contemporary views on the prevention and treatment of age-associated macular degeneration

Age-related macular degeneration (ARMD) is a major cause of blindness in old men.

Keywords

age-dependent macular degeneration, risk factors, treatment, prevention

1. Age-related Eye Disease study 2 (AREDS2) Research Group. Secondary analysesof the effects of lutein / zeaxanthin on age-related macular degeneration progression: AREDS report No. 3 // JAMA Ophthalmol. 2014. Vol. 132. P. 142–149.
2. Agtmael, T. V., Bruscner-Tuderman L. Basement membranes and human disease // Cell. Tissue Res. 2010. Vol. 339. P. 67–188.
3. Ambati, J., Atkinson J. P., Gelfand B. D. Immunology of age-related macular degeneration // Nat. Rev. Immunol. 2013. Vol. 13. P. 438–451.
4. Buschini, E., Piras A., Nuzzi R., Vercelli A. Age related macular degeneration and drusen: neuroinflamation in the retina // Progress in Neurobiology. 2011. Vol. 95, № 1. P. 14–25.
5. Carr, A. J., Smart J., Ramsden C. M. et al. Development of human embryonic stem cell therapies for age-related macular degeneration // Trends in Neurosciences. 2013. Vol. 36, № 7.P. 385–395.
6. Chew, E. Y., Clemons T. E., Agron E., et al. Age-related eye disease study research group/ Long term effects of vitamins C, E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 // Ophthalmol. 2013. Vol. 120. P. 1604–1611.
7. Falkner-Radler, C. I., Krebs I., Glittenberg C., et al. Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet after RPE cell-suspension in a randomized clinical study // British J. of Ophthalmology. 2011. Vol. 95, № 3. P. 370–575.
8. Fernandez-Robredo, P., Sancho A., Johnen S. et al. Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering // J. Ophtalmol. 2014. Vol. 2014. Article ID 510285. 13 p.
9. Figurska, M. Retinal pigment epithelial tears following ranibizumab therapy for fibrovascular retinal pigment epithelial detachment due to occult age-related macular degeneration // Med. Sci, Monit. 2012. Vol. 18, № 1. CR32–38.
10. Haller, J. A. Current anti-vascular endothelial growth factor during regimens: benefits and burden // Ophthalmology. 2013. Vol. 120, № 5, suppl. P. S3-S7.
11. Holz, F. G., SchmitzWalckenberg S., Fleckenstein M.Recent developments in the treatment of age-related macular degeneration // J. Clin. Invest. 2014. Vol. 124. P. 1430–1438.
12. Honda, S., Matsumiya W., Negi A. Polypoidal choroidal vasculopathy: clinical features and genetic predisposition // Ophthalmologica. 2014. Vol. 231. P. 59–74.
13. Hong, T., Tan A. G., Mitchell P., Wang J. J. A review and meta-analisis of the association between C-reactive protein and age-related macular degeneration курениеn // Surv. Ophthalmol. 2011. Vol. 56. P. 184–194.
14. Horie-Inoue, K., Inoue S. Genomic aspects of age-related macular degeneration // Biochem. Biophys. Res. Communic. 2014. Vol. 452. P. 263–275.
15. Howard, K. E., Klein B. E., Lee K. E., Klein R. Measures of body shape and adiposity as related to incidence of age-related eye diseases: observations from the Beaver dam eye study // Invest Ophthalmol. Vis. Sci. 2014. Vol. 55. P. 2592–2598.
16. Imai, D., Mori K., Horie-Inoue K. et al. CFH, VEGF and PEDF genotypes and the response to intravitreous injection of bevacizumab for the treatment of age-related macular degeneration // J. Ocul. Biol. Dis. Infor. 2010. № 3. P. 53–59.
17. Ishida, S. Lifestyle-related diseases and anti-aging ophthalmology: suppression of retinal and choroidal pathologies by inhibiting rennin-angiotensin // Nihon Ganka Gakkai Zasshi. 2009. Vol. 113, № 3. P. 403–422.
18. Kamao, H., Mandai M., Okamoto S., et al. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application // Stem Cell Rep. 2014. № 2. P. 205–218.
19. Kay, P., Yang Y. C., Paraoan L. Directional protein secretion by the retinal pigment epithelium: roles of retinal heath and the development of age-related macular degeneration // J. Cell. Moll. Med. 2013. Vol. 17. P. 833–843.
20. Lally, D. R., Gerstenblith A. T., Regillo C. D. Preferred therapies for neovascular age-related macular degeneration // Current Opinion in Ophtalmology. 2012. Vol. 23, № 3. P. 182–188.
21. Lee, S., Song S. I., Yu H. G. Current smoking is associated with a poor visual activity improvement after intravitreal ranibizumab therapy in patients with exudative age-related macular degeneration // J. Korean Med. Sci. 2013. Vol. 28. P. 269–274.
22. Liegl, R., Koenig S., Siedlecki J. et al. Temsirolimus inhibits proliferation and migration in retinal pigment epithelial and endothelial cells via mTor inhibition and decreases VEGF and PDGF expression // PLoS ONE. 2014. № 9. e88203.
23. Murray, M. T., Bongiorno P. B. Macular degeneration // Natural Medicine. Eds: M. T. Murray et al. 2006. Vol. 2. Ch. 187.P. 1859–1863.
24. Narimatsu, T., Ozawa Y., Miyake S. et al. Disruption of cell-cell junctions and induction of pathological cytokines in the retinal pigment epithelium of light-exposure mice // Invest. Ophthalmol. Vis. Sci. 2013. Vol. 54. P. 4555–4562.
25. Nita, M., Michalska K., Mazurek U., et al. Influence of ranibizumab treatment on the extracellular matrix in patients with neovascular age-related macular degeneration // Med. Sci. Monit. 2014. Vol. 20. P. 875–883.
26. Pons, M., Marin-Castaño M. E. Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD // Investigative Ophthalmology a. Visual Sciences. 2011. Vol. 52, № 6. P. 3842–3853.
27. Rennie, C. A., Stinge A., King E. A. et al. Can genetic risk information for age-related macular degeneration influence motivation to stop smoking? A pilot study // Eye (London). 2012. Vol. 26. P. 109–118.
28. Richer, S., Stiles W., Statkute L., et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial) // Optometry. 2004. Vol. 75, P. 216–230.
29. Rofagha, S., Bhisitkul R. B., Royer D. S. et al. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP) // ophthalmology. 2013. Vol. 120, № 11. P. 2292–2299.
30. Sui, G. V., Liu G. C., Liu G. V., et al. Is sunlight exposurea risk factor for age-related macular degeneration? A systematic review and meta-analysis // Br. J. Ophthalmol. 2013. Vol. 97. P. 389–394.
31. Velitta, S., Garcia-Medina J. J., Garcia-Layana et al. Smoking and age-related macular degeneration: review and update //J. Ophthalmol. 2013. 895147.
32. Wang, A. L., Lukas T. J., Yuan M., et al. Changes in retinal pigment epithelium related to cigarette smoke: possible relevance to smoking as a risk factor for age-related macular degeneration // PLoS ONE. 2009. № 4. e5304.
33. Wong, W. L., Su X., Li X., et al. Global prevalence of agerelated macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis // Lancet Global Health. 2014. Vol. 2. e106-e116.
34. Wood, A., Margrain Th., Binns A. M. Detection of early agerelated macular degeneration using novel functional parameters of the focal cone electroretinogram // PLOS ONE. May 2014. Vol. 9, Issue 5. e96742.
35. Wu, J., Uchino M., Sastry S. M., Schaumberg D. A. Agerelated macular degeneration and incidence of cardiovascular disease: a systematic review and meta-analisis // PLOS ONE. 2014. e89600.